ABSTRACT
Small quantities of the floppy bimesogen di(4PPB5)3Si were dissolved in an anticlinic liquid crystal consisting of a mixture of left-handed and right-handed TFMHPOBC, with enantiomer excess X=0.2 . The bimesogen dopant was found to promote anticlinic order with an anticlinic interaction coefficient per molecule udopant smaller than, but of the same order as, that of the rigid bent-core dopant P-7PIMB. For both dopants udopant was found to be much larger than that due to a pair of TFMHPOBC molecules in adjacent layers. The results are examined in terms of both the flexibility of the group linking the two legs of each dopant, as well as their chemical structure.
ABSTRACT
Small quantities of the bent-core mesogen P-7PIMB were dissolved in an anticlinic liquid crystal consisting of a mixture of left- and right-handed TFMHPOBC, with enantiomer excess X=0.2. The bent-core dopant promotes anticlinic order at higher temperatures, but becomes less effective in suppressing the synclinic phase at the reentrant synclinic transition due to an orientational transition of the dopant within the calamitic TFMHPOBC matrix. Measurements of the anticlinic-synclinic electric-field switching threshold as a function of temperature and dopant concentration facilitate a determination of the component of the anticlinic interaction coefficient U that is due to the bent-core dopant. It is found that the value of U per bent-core molecule is much larger than the corresponding value for a pair of TFMHPOBC molecules in adjacent smectic layers.
ABSTRACT
BACKGROUND: Recent studies from our laboratory have demonstrated that androgen-induced basal norepinephrine (NE) release is responsible for the onset of proliferation in seminal vesicle smooth muscle (SVM) cells during early puberty. With subsequent sexual maturation, SVM was irreversibly differentiated to an androgen-resistant-amitotic state in which basal NE release remained elevated and resistant to androgen withdrawal or repletion. Based on these findings, we hypothesized that this irreversible elevation of basal NE release during pubertal development is caused, at least in part, by the down-regulation of pre-synaptic NE feedback inhibition, secondary to irreversible reduction in the expression of neuronal (pre-synaptic) alpha(2)-adrenoceptors. Functional alpha(2)-adrenoceptors are selectively localized to pre-synaptic sites in SVM. METHODS: To test this hypothesis, we employed ligand binding techniques with [(3)H]RX821002, an antagonist which labeled all alpha(2)-adrenoceptor sub-types. Initial experiments focused on analysis of competitor specificity to identify the predominant alpha(2)-adrenoceptor sub-type in SVM. Subsequently, we quantified the changes in the receptor concentration (B(max)) for [(3)H]RX821002 at the point of maximal dihydrotestosterone (DHT)-induced change in basal NE release. RESULTS: Based on competitor specificity for [(3)H]RX821002, the alpha(2D)-adrenoceptor sub-type predominated in SVM. We treated pre-pubertal castrate animals with DHT for 7 days, which was previously demonstrated to maximally induce basal NE release. This treatment reduced the pre-synaptic alpha(2)-adrenoceptor B(max) 4-fold. In animals which had been castrated as adults, the B(max) for [(3)H]RX821002 remained irreversibly suppressed. CONCLUSIONS: The DHT-dependent reduction in the alpha(2)-adrenoceptor concentration is consistent with the developmental pattern of increased basal NE release. These findings support the hypothesis that the down-regulation of pre-synaptic NE feedback is mechanistically involved in the irreversible elevation of basal NE release. NE mediates proliferation in SVM in early pubertal development. Thus, the androgen-dependent pubertal growth of smooth muscle cells may be indirectly controlled at the level of neurotransmission.
